Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares MONACO, July 02, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared: a cash dividend of $0.50 per share on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares (the “Series C Preferred Shares”) (NYSE: SB.PR.C) for the period from April 30,...
Safe Bulkers Announces Annual Meeting of Stockholders MONACO, June 27, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that its Board of Directors has called an annual meeting of the stockholders to be held on September 16, 2025, at 15:00 local time at the Hotel Hermitage Monte-Carlo, Square Beaumarchais, Monte-Carlo, 98000, Monaco. Stockholders of record at the close of business on July 21, 2025, will be entitled to receive notice of, and to vote at, the annual meeting, or any ad...
Star Bulk Announces Share Buyback of 1,985,169 Shares at an Average Price of $16.21 Per Share for a Total of $32.22 Million ATHENS, Greece, June 16, 2025 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), today announced that the Company has bought back 1,985,169 of its shares since March 31st, 2025 for a total of $32.22 million at an average purchase price per share of $16.21. As of today, following the cancellation of the repurchased shares the total number of issued and outstanding SBLK shares is 115,603,652. About Star BulkStar Bulk is a g...
Safe Bulkers, Inc. Announces Availability of 2024 Sustainability Report MONACO, June 03, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company’s 2024 Sustainability Report is available for download and can be accessed from its website using the link provided below. The 2024 Sustainability Report has been prepared in accordance with the Global Reporting Initiative (GRI) Sustainability Reporting Guidelines, 'in accordance with the GRI Standards', and the Sustainability Ac...
A director at Star Bulk Carriers Corp sold 14,245 shares at 16.440USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
The trade war de-escalation has offered some breathing space for investors and driven positive sentiment, but we expect headline volatility to continue. Much of the focus will also be on geopolitical developments. In this report we have reviewed a large number of Turkish non-financial corporates, added the idea to buy SGLSJ'29 and closed the idea to buy WE SODA.
Safe Bulkers, Inc. Reports First Quarter 2025 Results and Declares Dividend on Common Stock MONACO, May 19, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three-month periods ended March 31, 2025. The Board of Directors (“the Board”) of the Company also declared a cash dividend of $0.05 per share of outstanding common stock. Financial highlights In million U.S. Dollars except per share dataQ1 2025Q42024Q32024Q22024Q12024Net revenues64.37...
Star Bulk Carriers Corp. Reports Net Profit of $0.5 Million For the First Quarter of 2025, and Declares Quarterly Dividend of $0.05 Per Share ATHENS, Greece, May 14, 2025 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), a global shipping company focusing on the transportation of dry bulk cargoes, today announced its unaudited financial and operating results for the first quarter of 2025 and the amendment of its dividend policy to pay a minimum quarterly dividend of $0.05 per share. Unless otherwise indicated or unless the context requires otherwi...
Star Bulk Announces Results of Its 2025 Annual Meeting of Shareholders ATHENS, Greece, May 14, 2025 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), today announced that the Company’s Annual Meeting of Shareholders was duly held today in Cyprus pursuant to a Notice of Annual Meeting of Shareholders dated March 25, 2025 (“Notice”). At the meeting, each of the following proposals, which are set forth in more detail in the Notice and the Company’s Proxy Statement were approved and adopted:1. The re-election of Messrs. Petros Pappas, Arne Blystad an...
Safe Bulkers, Inc. Sets Date for the First Quarter 2025 Results, Conference Call, and Webcast Earnings Release: Monday, May 19, 2025, After Market Closes Conference Call and Webcast: Tuesday, May 20, 2025, at 10:00 A.M. Eastern Time MONACO, May 13, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that it will release its results for the first quarter ended March 31, 2025, after the market closes in New York on Monday, May 19, 2025. On Tuesday, May 20, 2025, at 10:00 A.M. Eastern Ti...
A director at Novo Nordisk AS sold 40,000 shares at 450.528DKK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Q1 revenue missed expectations on lower reimbursement revenue, while operating profit was a beat, as opex was below our forecast and consensus. The 2025 guidance was maintained for opex of DKK2,000m–2,500m. We believe the next potential share-price catalyst is the top-line results from the phase Ib dapiglutide trial in Q2e. We reiterate our BUY, but have cut our target price to DKK950 (1,000).
Star Bulk Announces Date for the Release of First Quarter Ended March 31, 2025, Results, Conference Call, and Webcast ATHENS, Greece, May 08, 2025 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), today announced that it will release its results for the first quarter ended March 31, 2025, after the market closes in New York on Wednesday, May 14, 2025. Star Bulk's management team will host a conference call to discuss the Company's financial results on Thursday, May 15, 2025, at 11:00 a.m. Eastern Time (ET). Conference Call details: Participants ...
Q1 LCY figures beat our forecasts, while the 2025 guidance was cut to 13–21% LCY sales growth YOY and 16–24% LCY operating profit growth YOY due to weaker GLP-1 sales. We have lowered our rebate for US Ozempic but maintain our 52% Wegovy rebate (in line with the Q1 rebate when adjusting for de-stocking). We reiterate our BUY and DKK900 target price.
We see ~30% downside risk to dry bulk asset values on historical EV/EBITDA multiples and the prevailing 1-year TCs. Thus, given our muted near-term outlook on the dry bulk segment, we believe valuations must converge lower. However, at Star Bulk’s heavily discounted 0.67x EV/GAV (bulker peer group: 0.72x), we believe much of the downside risk is priced in and leaves a fair risk/reward, despite the risk of no DPS in Q1 for the first time since 2020. Hence, we reiterate our HOLD but have lowered o...
We maintain our cautious stance on dry bulk near-term and see potential for negative momentum in asset values yet to be supported by underlying freight markets. However, we still believe Safe Bulker’s discounted valuation (0.38x P/NAV and 0.65x EV/GAV) and earnings visibility more than compensates for the potential downside risk and offers undervalued dry bulk exposure to investors. Hence, we reiterate our BUY, but have lowered our target price to USD4.1 (4.2).
We forecast a soft Q1, with 17.3% LCY sales growth and 13.8% LCY operating profit growth due to subdued prescriptions. While we estimate Ozempic sales c0.5% below consensus, we are c1.2% above for Wegovy, as we include DKK1bn in sales related to Wegovy US inventories. We see likely relief from potential unchanged 2025 LCY guidance, supported by improved Wegovy supply and fading pressure from compounders. We reiterate our BUY and DKK900 target price.
We expect an uneventful Q1 report, with investor focus on top-line results from the dapiglutide phase Ib obesity trial (due in Q2), which could help provide clarity on the positioning of the molecule in obesity and inflammation. For petrelintide, we have reduced our peak sales forecast to cUSD10.0bn (cUSD10.8bn) on increased competition from GUBamy. We reiterate our BUY but have cut our target price to DKK1,000 (1,150).
The US Trade Representative on 17 April published revised US port fees with significant changes to the initial proposal based on industry feedback. In its current form, the fees will primarily discourage use of Chinese-controlled maritime trade services to the US, and directly affect the use of Chinese-built vessels in US ports (with several considerable exemptions to avoid harm to US trade). The previous broader fees based on fleet composition and share of Chinese-built vessels has been scrappe...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.